High-Salt Attenuates the Efficacy of Dapagliflozin in Tubular Protection by Impairing Fatty Acid Metabolism in Diabetic Kidney Disease.

High-Salt Attenuates the Efficacy of Dapagliflozin in Tubular Protection by Impairing Fatty Acid Metabolism in Diabetic Kidney Disease.
复制标题

高盐通过损害糖尿病肾病中的脂肪酸代谢来削弱达格列净的肾小管保护功效

DOI:
10.3389/fphar.2021.741087
复制
发表时间:
2021
影响因子:
5.6
通讯作者:
Xue Y
Xue Y
中科院分区:
医学2区
文献类型:
--
作者:
Zou M;Chen Y;Zheng Z;Sheng S;Jia Y;Wang X;Ren S;Yang Y;Li X;Dong W;Guan M;Zhang Q;Xue Y

文献摘要

参考文献

被引文献

相似文献

High-salt intake leads to kidney damage and even limits the effectiveness of drugs. However, it is unclear whether excessive intake of salt affects renal tubular energy metabolism and the efficacy of dapagliflozin on renal function in diabetic kidney disease (DKD). In this study, we enrolled 350 DKD patients and examined the correlation between sodium level and renal function, and analyzed influencing factors. The results demonstrated that patients with macroalbuminuria have higher 24 h urinary sodium levels. After establishment of type 2 diabetes mellitus model, the animals received a high-salt diet or normal-salt diet. In the presence of high-salt diet, the renal fibrosis was aggravated with fatty acid metabolism dysregulation. Furthermore, Na+/K+-ATPase expression was up-regulated in the renal tubules of diabetic mice, while the fatty acid metabolism was improved by inhibiting Na+/K+-ATPase of renal tubular epithelial cells. Of note, the administration with dapagliflozin improved renal fibrosis and enhanced fatty acid metabolism. But high salt weakened the above-mentioned renal protective effects of dapagliflozin in DKD. Similar results were recapitulated in vitro after incubating proximal tubular epithelial cells in high-glucose and high-salt medium. In conclusion, our results indicate that high salt can lead to fatty acid metabolism disorders by increasing Na+/K+-ATPase expression in the renal tubules of DKD. High salt intake diminishes the reno-protective effect of dapagliflozin in DKD.
DOI: 10.1007/s00125-005-1824-1
发表时间: 2005-08-01
期刊: DIABETOLOGIA
影响因子: 8.2
作者:
Hu, G;Jousilahti, P;Tuomilehto, J
通讯作者: Tuomilehto, J
DOI: 10.1161/01.hyp.35.2.544
发表时间: 2000-02-01
期刊: HYPERTENSION
影响因子: 8.3
作者:
He, JA;Whelton, PK;Klag, MJ
通讯作者: Klag, MJ
DOI: 10.2337/dc15-2688
发表时间: 2016-11-01
期刊: DIABETES CARE
影响因子: 16.2
作者:
Daniele, Giuseppe;Xiong, Juan;Abdul-Ghani, Muhammad
通讯作者: Abdul-Ghani, Muhammad
DOI: 10.1056/nejmoa0907355
发表时间: 2010-02-18
期刊: The New England journal of medicine
影响因子: --
作者:
Bibbins-Domingo K;Chertow GM;Coxson PG;Moran A;Lightwood JM;Pletcher MJ;Goldman L
通讯作者: Goldman L
白蛋白诱导的管状上皮细胞的细胞外囊泡通过靶向 Klotho 促进 M1 巨噬细胞表型
DOI: 10.1016/j.ymthe.2019.05.019
发表时间: 2019-08-07
期刊: MOLECULAR THERAPY
影响因子: 12.4
作者:
Jia, Yijie;Zheng, Zongji;Xue, Yaoming
通讯作者: Xue, Yaoming